Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2006-02-13 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FOIX (09000), Ariege
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT : revenue, balance sheet and financial ratios
PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FOIX (09000),
this company of category PME
shows in 2017 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT (SIREN 488576364)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 786 013 €
Net income
74 613 €
107 967 €
193 758 €
134 918 €
110 215 €
104 823 €
54 271 €
71 511 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
126 792 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4.0%
Revenue and income statement
In 2024, PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT generates positive net income of 75 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 72 k€ -> 75 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
74 613 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.686%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.764%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
30.706
19.92
17.021
3.098
3.261
8.097
6.86
10.686
Financial autonomy
65.18
69.264
71.346
76.782
81.901
79.461
80.894
74.764
Repayment capacity
2.965
None
None
None
None
None
None
None
Cash flow / Revenue
5.638%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
10.692024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent
In 2024, the debt ratio of PHARMACIE BOUSQUET ANNIE ... (10.69) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
74.76%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Excellent
In 2024, the financial autonomy of PHARMACIE BOUSQUET ANNIE ... (74.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 226.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
226.928
Liquidity indicators evolution PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
255.467
228.305
252.16
193.113
257.02
291.303
270.689
226.928
Interest coverage
2.152
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
226.932024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good-11 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE BOUSQUET ANNIE ... (226.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
182 477 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
39
0
0
0
0
0
0
0
Customer payment term (days)
1
0
0
0
0
0
0
0
Supplier payment term (days)
47
0
0
0
0
0
0
0
Positioning of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT is estimated at
1 041 652 €
(range 725 390€ - 1 558 371€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
725k€1041k€1558k€
1 041 652 €Range: 725 390€ - 1 558 371€
NAF 5 année 2024
Valuation method used
Net Income Multiple
74 613 €
×
14.0x
=1 041 653 €
Range: 725 390€ - 1 558 372€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT with other companies in the same sector:
Frequently asked questions about PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT
What is the revenue of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT ?
The revenue of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT in 2017 is 1.8 M€.
Is PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT profitable?
Yes, PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT generated a net profit of 75 k€ in 2024.
Where is the headquarters of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT ?
The headquarters of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT is located in FOIX (09000), in the department Ariege.
Where to find the tax return of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT ?
The tax return of PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT operate?
PHARMACIE BOUSQUET ANNIE ET BOUSQUET VINCENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart